Recombinant human erythropoietin in mildly anemic women before total hysterectomy

Απλή σελίδα τεκμηρίου
dc.contributor.authorDousias, V.en
dc.contributor.authorParaskevaidis, E.en
dc.contributor.authorDalkalitsis, N.en
dc.contributor.authorTsanadis, G.en
dc.contributor.authorNavrozoglou, I.en
dc.contributor.authorLolis, D.en
dc.date.accessioned2015-11-24T18:54:52Z
dc.date.available2015-11-24T18:54:52Z
dc.identifier.issn0390-6663-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/18763
dc.rightsDefault Licence-
dc.subjectAdulten
dc.subjectAnemia/diagnosis/*drug therapyen
dc.subjectDose-Response Relationship, Drugen
dc.subjectDrug Administration Scheduleen
dc.subjectErythropoietin/*administration & dosageen
dc.subjectFemaleen
dc.subjectFollow-Up Studiesen
dc.subjectHemoglobins/drug effectsen
dc.subjectHumansen
dc.subjectHysterectomy/methodsen
dc.subjectLeiomyoma/pathology/*surgeryen
dc.subjectMiddle Ageden
dc.subjectPreoperative Care/methodsen
dc.subjectRecombinant Proteinsen
dc.subjectReference Valuesen
dc.subjectReticulocyte Counten
dc.subjectSeverity of Illness Indexen
dc.subjectTreatment Outcomeen
dc.subjectUterine Neoplasms/pathology/*surgeryen
dc.titleRecombinant human erythropoietin in mildly anemic women before total hysterectomyen
heal.abstractThe purpose of this study was to investigate the efficacy of preoperative recombinant human erythropoietin (rHuEPO) treatment in a group of mildly anemic women. METHODS: This randomized controlled study included 50 healthy, mildly anemic women who underwent total hysterectomy for leiomyomas. The study group (Group A) included 23 women who received rHuEPO 600 U/kg once weekly for three weeks, plus iron supplementation. The control group (Group B) included 27 women who received only iron supplementation. Blood samples were obtained on days -14, -7, 0, +3, +7 and +14. RESULTS: An increase in preoperative mean hemoglobin concentration was noted in both groups; however, the increase was significantly higher in Group A throughout the study period. Mean reticulocyte count was also significantly higher in this group, whereas mean ferritin level was significantly lower. No postoperative transfusion was needed in Group A, whereas five women were transfused in Group B. CONCLUSION: Rapid and persistent improvement of hematologic parameters makes the use of rHuEPO for preoperative treatment of mildly anemic women with benign uterine pathology a very interesting approach.en
heal.accesscampus-
heal.fullTextAvailabilityTRUE-
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/14664421-
heal.journalNameClin Exp Obstet Gynecolen
heal.journalTypepeer-reviewed-
heal.languageen-
heal.publicationDate2003-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.typejournalArticle-
heal.type.elΆρθρο Περιοδικούel
heal.type.enJournal articleen

Αρχεία

Φάκελος/Πακέτο αδειών

Προβολή: 1 - 1 of 1
Μικρογραφία εικόνας
Ονομα:
license.txt
Μέγεθος:
1.74 KB
Μορφότυπο:
Item-specific license agreed upon to submission
Περιγραφή:
Κατεβάστε

Συλλογές

Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ